Press Mention
Reverse Mergers Say Hey as Biotechs Trade Low, Hunt for Alternatives and Launch Few IPOs
Endpoints News
May 4, 2023
Cooley partner Richard Segal was quoted in Endpoints News on current trends in the biotechnology industry, such as reverse mergers and initial public offerings.